Skip to main content

MEJORA DE LAS PROPIEDADES BIOQUIMICAS DE RETROTRANSCRIPTASAS DEL VIH, UTILES EN APLICACIONES BIOTECNOLOGICAS

PID2019-104176RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses

  • Huang, Tianguang
  • Sun, Lin
  • Kang, Dongwei
  • Poongavanam, Vasanthanathan
  • Liu, Xinyong
  • Zhan, Peng
  • Menéndez-Arias, Luis
Recent coronavirus outbreaks of SARS-CoV-1 (2002–2003), MERS-CoV (since 2012), and SARS-CoV-2 (since the end of 2019) are examples of how viruses can damage health care and generate havoc all over the world. Coronavirus can spread quickly from person to person causing high morbidity and mortality. Unfortunately, the antiviral armamentarium is insufficient to fight these infections. In this chapter, we provide a detailed summary of the current situation in the development of drugs directed against pandemic human coronaviruses. Apart from the recently licensed remdesivir, other antiviral agents discussed in this review include molecules targeting viral components (e.g., RNA polymerase inhibitors, entry inhibitors, or protease inhibitors), compounds interfering with virus-host interactions, and drugs identified in large screening assays, effective against coronavirus replication, but with an uncertain mechanism of action., Financial support from the Key Project of NSFC for International Cooperation (No. 81420108027), and the Key Research and Development Project of Shandong Province (No. 2017CXGC1401, 2019JZZY021011, 2020SFXGFY08) are gratefully acknowledged. Work in Madrid was supported by grants of the Ministry of Science and Innovation of Spain (PID2019-104176RB-I00/AEI/10.13039/501100011033) and CSIC (2019AEP001). An institutional grant of the Fundación Ramón Areces to the CBMSO is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

An Update on Antiretroviral Therapy

  • Menéndez-Arias, Luis
  • Martín-Alonso, Samara
  • Frutos-Beltrán, Estrella
Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) still claim many lives across the world. However, research efforts during the last 40 years have led to the approval of over 30 antiretroviral drugs and the introduction of combination therapies that have turned HIV infection into a chronic but manageable disease. In this chapter, we provide an update on current available drugs and treatments, as well as future prospects towards reducing pill burden and developing long-acting drugs and novel antiretroviral therapies. In addition, we summarize efforts to cure HIV, including pharmaceutical strategies focused on the elimination of the virus., This work was supported by grants of the Ministry of Science and Innovation of Spain (BIO2016-76716-R (AEI/FEDER, UE) and PID2019-104176RB-I00/AEI/10.13039/501100011033 awarded to L.M.-A.), and CSIC (2019AEP001 awarded to L.M.-A.). S.M.-A. is a predoctoral fellow of the Ministry of Science and Innovation of Spain (BES-2017-079836). An institutional grant of the Fundación Ramón Areces to the CBMSO is also acknowledged., Peer reviewed